Positron Emission Tomography (PET) Imaging of Participants With Confirmed Prostate Cancer Using 64Cu-SAR-bisPSMA (PROPELLER)
Clinical trial NCT04839367 · COMPLETED
Trial details
- NCT number
- NCT04839367
- Sponsor
- Clarity Pharmaceuticals Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-13
- Primary completion
- 2022-10-19
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.